Skip to content

Passage BIO, Inc.

PASG

CIK 0001787297

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$40.1M
+29.7% YoY Q1 May 2026
EPS Diluted (TTM)
−$12.63
+31.8% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$68.24M
Q1 May 2026
Cash
$33.34M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
3.21M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings